Warren Buffett's Berkshire Hathaway buys OxyChem for $9.7 billion

Core Insights - Berkshire Hathaway is acquiring Occidental Petroleum's chemical division, OxyChem, for $9.7 billion, marking a significant move as Warren Buffett prepares to transition leadership to Vice Chair Greg Abel in January [2][3]. Acquisition Details - The acquisition of OxyChem, which produces chemicals like chlorine and vinyl chloride, is seen as a strategic fit alongside Berkshire's existing portfolio, particularly with Lubrizol, acquired in 2011 for $9 billion [5][6]. - OxyChem generated $213 million in pretax earnings for Occidental in the second quarter, a decrease from nearly $300 million the previous year [7]. Financial Context - Occidental Petroleum is utilizing proceeds from the sale to reduce its debt, aiming to lower principal debt below $15 billion, following a strategy that includes selling off approximately $4 billion in assets since the CrownRock acquisition [8][7]. - Berkshire Hathaway holds over 28% of Occidental's stock and has significant preferred shares, indicating a strong financial relationship between the two companies [9][10]. Future Outlook - The OxyChem deal is expected to close in the fourth quarter of this year, further solidifying Berkshire's position in the chemical sector [11].